F12
Conditions
Interventions
Group 1: Patients diagnosed with cannabis dependence at the beginning, at intervals during and after appropriate withdrawal treatment, detoxification treatment or addiction rehabilitation
Group 2: Ind
Sponsors
Institut für Rechtsmedizin
Eligibility
Sex/Gender
All
Age
14 Years to No maximum
Inclusion criteria
Inclusion criteria: - Belonging to one of the groups mentioned - Voluntary consent - Provision of information on medical and cannabis history - Individual assessment of the reasonableness of the measures associated with participation in the study - Minimum age in group 2: 21 years
Exclusion criteria
Exclusion criteria: - Expectation or possibility of an increased risk of complications during the procedures to be performed - Lack of capacity to give consent - Lack of willingness to cooperate - Group 2: pregnant and breastfeeding individuals and, following individual assessment, individuals with physical or mental impairments if the health risk associated with participation in the study is increased by the respective impairment - Group 2: CUDIT-R score of 13 or higher
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Correlation of the identified biomarkers in blood and urine samples in relation to the individual cannabis use behaviour (including CUDIT-R score; CUDIT = Cannabis Use Disorders Identification Test) | — |
Secondary
| Measure | Time frame |
|---|---|
| Development of a model based on the biomarkers found to distinguish between the groups | — |
Countries
Germany
Contacts
Public ContactErik Kröger
Institut für Rechtsmedizin
Outcome results
None listed